Anuj Agarwala

Hematology Indianapolis, IN Male
NPI: 1225236201
Total Payments
$12,345
2024 Payments
$724.95
Companies
54
Transactions
525
Medicare Patients
2,739
Medicare Billing
$247,697

Payment Breakdown by Category

Food & Beverage$7,691 (62.3%)
Consulting$4,443 (36.0%)
Education$211.64 (1.7%)
Other$0.00 (0.0%)

Payments by Nature

Nature of Payment Amount Transactions Share
Food and Beverage $7,691 508 62.3%
Consulting Fee $4,443 3 36.0%
Education $211.64 14 1.7%

Top Paying Companies

Company Total Records Latest Year
AstraZeneca Pharmaceuticals LP $2,575 43 $0 (2022)
Eli Lilly and Company $1,875 1 $0 (2023)
Novartis Pharmaceuticals Corporation $1,170 74 $0 (2020)
E.R. Squibb & Sons, L.L.C. $808.01 54 $0 (2020)
Lilly USA, LLC $666.14 4 $0 (2024)
PFIZER INC. $632.78 58 $0 (2020)
Genentech USA, Inc. $488.97 36 $0 (2020)
Janssen Biotech, Inc. $469.29 29 $0 (2020)
Merck Sharp & Dohme Corporation $461.64 34 $0 (2020)
Amgen Inc. $368.50 29 $0 (2020)

Payment History by Year

Year Amount Transactions Top Company
2024 $724.95 2 Lilly USA, LLC ($625.00)
2023 $1,875 1 Eli Lilly and Company ($1,875)
2022 $2,077 3 AstraZeneca Pharmaceuticals LP ($1,943)
2021 $30.93 2 AstraZeneca Pharmaceuticals LP ($19.01)
2020 $338.36 22 Novartis Pharmaceuticals Corporation ($76.73)
2019 $2,511 162 Novartis Pharmaceuticals Corporation ($344.72)
2018 $2,497 170 Novartis Pharmaceuticals Corporation ($420.50)
2017 $2,291 163 Novartis Pharmaceuticals Corporation ($327.91)

All Payment Transactions

525 individual payment records from CMS Open Payments — Page 1 of 21

Date Company Product Nature Form Amount Type
12/20/2024 Lilly USA, LLC — Consulting Fee Cash or cash equivalent $625.00 General
09/25/2024 Aveo Pharmaceuticals, Inc. FOTIVDA (Drug) Education In-kind items and services $99.95 General
Category: Oncology
12/21/2023 Eli Lilly and Company — Consulting Fee Cash or cash equivalent $1,875.00 General
12/01/2022 PharmaEssentia USA Corporation BESREMI (Drug) Education In-kind items and services $12.25 General
Category: Oncology
11/22/2022 AstraZeneca Pharmaceuticals LP IMFINZI (Biological) Consulting Fee Cash or cash equivalent $1,942.50 General
Category: Oncology
10/05/2022 Kite Pharma, Inc. — Food and Beverage In-kind items and services $122.03 General
10/18/2021 AstraZeneca Pharmaceuticals LP — Education In-kind items and services $19.01 General
06/01/2021 Gilead Sciences, Inc. — Education In-kind items and services $11.92 General
03/10/2020 E.R. Squibb & Sons, L.L.C. OPDIVO (Biological) Food and Beverage Cash or cash equivalent $14.43 General
Category: Oncology
03/06/2020 Novartis Pharmaceuticals Corporation KISQALI (Drug), PIQRAY Food and Beverage In-kind items and services $16.56 General
Category: ONCOLOGY
03/04/2020 Janssen Biotech, Inc. DARZALEX (Drug) Food and Beverage In-kind items and services $15.96 General
Category: Oncology
03/03/2020 E.R. Squibb & Sons, L.L.C. OPDIVO (Biological) Food and Beverage Cash or cash equivalent $21.13 General
Category: Oncology
03/02/2020 AstraZeneca Pharmaceuticals LP TAGRISSO (Drug) Food and Beverage In-kind items and services $19.25 General
Category: Oncology
02/29/2020 AbbVie Inc. VENCLEXTA (Drug) Food and Beverage In-kind items and services $15.63 General
Category: ONCOLOGY
02/28/2020 PFIZER INC. INLYTA (Drug), BAVENCIO, LORBRENA Food and Beverage In-kind items and services $11.72 General
Category: ONCOLOGY
02/18/2020 Merck Sharp & Dohme Corporation KEYTRUDA (Biological) Food and Beverage In-kind items and services $14.34 General
Category: ONCOLOGY
02/14/2020 Novartis Pharmaceuticals Corporation MEKINIST (Drug), TAFINLAR Food and Beverage In-kind items and services $13.88 General
Category: ONCOLOGY
02/12/2020 EMD Serono, Inc. Bavencio (Drug) Food and Beverage In-kind items and services $15.04 General
Category: Oncology
02/11/2020 Amgen Inc. Vectibix (Biological) Food and Beverage In-kind items and services $11.35 General
Category: Oncology
02/05/2020 Merck Sharp & Dohme Corporation KEYTRUDA (Biological), LYNPARZA Food and Beverage In-kind items and services $18.41 General
Category: ONCOLOGY
01/31/2020 Novartis Pharmaceuticals Corporation ADAKVEO (Biological) Food and Beverage In-kind items and services $21.15 General
Category: HEMATOLOGY
01/29/2020 Karyopharm Therapeutics Inc. XPOVIO (Drug) Food and Beverage In-kind items and services $17.01 General
Category: Oncology
01/27/2020 Novartis Pharmaceuticals Corporation ADAKVEO (Biological) Food and Beverage In-kind items and services $13.80 General
Category: HEMATOLOGY
01/20/2020 Novartis Pharmaceuticals Corporation KISQALI (Drug), PIQRAY Food and Beverage In-kind items and services $11.34 General
Category: ONCOLOGY
01/17/2020 Clovis Oncology, Inc. Rubraca (Drug) Food and Beverage In-kind items and services $16.30 General
Category: Oncology
123…21»

Medicare Billing by Year

Year Procedures Beneficiaries Services Submitted Medicare Paid
2023 9 569 733 $102,977 $48,585
2022 11 578 759 $108,827 $55,580
2021 11 748 1,005 $141,088 $74,995
2020 14 844 1,154 $144,086 $68,538
Total Patients
2,739
Total Services
3,651
Medicare Billing
$247,697
Procedure Codes
64

All Medicare Procedures & Services

64 procedure records from CMS Medicare Utilization — Page 1 of 3

HCPCS Description Setting Year Patients Services Charges Medicare Paid Ratio
99214 Established patient office or other outpatient visit, 30-39 minutes Facility 2023 97 142 $20,367 $9,202 45.2%
99232 Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes Facility 2023 75 117 $12,753 $6,694 52.5%
99214 Established patient office or other outpatient visit, 30-39 minutes Office 2023 67 106 $15,446 $6,672 43.2%
99213 Established patient office or other outpatient visit, 20-29 minutes Facility 2023 75 95 $8,474 $4,211 49.7%
99215 Established patient office or other outpatient visit, 40-54 minutes Facility 2023 29 33 $6,204 $3,396 54.7%
99213 Established patient office or other outpatient visit, 20-29 minutes Office 2023 66 71 $6,386 $3,004 47.0%
99223 Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes Facility 2023 20 22 $6,754 $2,914 43.1%
99222 Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes Facility 2023 28 29 $6,032 $2,872 47.6%
99204 New patient office or other outpatient visit, 45-59 minutes Office 2023 29 29 $5,713 $2,832 49.6%
99205 New patient office or other outpatient visit, 60-74 minutes Office 2023 13 13 $3,328 $1,785 53.6%
99215 Established patient office or other outpatient visit, 40-54 minutes Office 2023 14 17 $3,196 $1,747 54.7%
99204 New patient office or other outpatient visit, 45-59 minutes Facility 2023 20 20 $3,940 $1,590 40.4%
99205 New patient office or other outpatient visit, 60-74 minutes Facility 2023 11 11 $2,816 $1,098 39.0%
99212 Established patient office or other outpatient visit, 10-19 minutes Office 2023 25 28 $1,568 $566.79 36.1%
99214 Established patient office or other outpatient visit, 30-39 minutes Facility 2022 85 129 $16,114 $9,240 57.3%
99232 Follow-up hospital inpatient care per day, typically 25 minutes Facility 2022 84 163 $17,767 $8,737 49.2%
99214 Established patient office or other outpatient visit, 30-39 minutes Office 2022 94 129 $16,023 $7,954 49.6%
99223 Initial hospital inpatient care per day, typically 70 minutes Facility 2022 38 40 $12,280 $6,012 49.0%
99204 New patient office or other outpatient visit, 45-59 minutes Facility 2022 32 32 $6,304 $3,119 49.5%
99215 Established patient office or other outpatient visit, 40-54 minutes Office 2022 24 27 $4,958 $2,954 59.6%
99205 New patient office or other outpatient visit, 60-74 minutes Facility 2022 19 19 $4,864 $2,646 54.4%
99205 New patient office or other outpatient visit, 60-74 minutes Office 2022 18 18 $4,608 $2,509 54.4%
99222 Initial hospital inpatient care per day, typically 50 minutes Facility 2022 23 24 $4,992 $2,450 49.1%
99213 Established patient office or other outpatient visit, 20-29 minutes Office 2022 43 50 $4,246 $2,339 55.1%
99213 Established patient office or other outpatient visit, 20-29 minutes Facility 2022 47 52 $4,400 $2,256 51.3%
123»

About Anuj Agarwala

Anuj Agarwala is a Hematology healthcare provider based in Indianapolis, Indiana. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/11/2007. The National Provider Identifier (NPI) number assigned to this provider is 1225236201.

According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Anuj Agarwala has received a total of $12,345 in payments from pharmaceutical and medical device companies, with $724.95 received in 2024. These payments were reported across 525 transactions from 54 companies. The most common payment nature is "Food and Beverage" ($7,691).

As a Medicare-enrolled provider, Agarwala has provided services to 2,739 Medicare beneficiaries, totaling 3,651 services with total Medicare billing of $247,697. Data is available for 4 years (2020–2023), covering 64 distinct procedure/service records.

Practice Information

  • Specialty Hematology
  • Other Specialties Hematology & Oncology, Medical Oncology
  • Location Indianapolis, IN
  • Active Since 07/11/2007
  • Last Updated 09/06/2023
  • Taxonomy Code 207RH0000X
  • Entity Type Individual
  • NPI Number 1225236201

Products in Payments

  • IMFINZI (Biological) $1,943
  • OPDIVO (Biological) $428.54
  • KEYTRUDA (Biological) $349.53
  • TAGRISSO (Drug) $341.52
  • DARZALEX (Drug) $298.54
  • Abraxane (Drug) $294.99
  • GILOTRIF (Drug) $276.04
  • AFINITOR (Drug) $227.16
  • TECENTRIQ (Biological) $179.79
  • TASIGNA (Drug) $158.33
  • EMPLICITI (Biological) $153.96
  • MEKINIST (Drug) $141.56
  • JADENU (Drug) $140.94
  • ELIQUIS (Drug) $139.20
  • Imbruvica (Drug) $131.62
  • CHANTIX (Drug) $124.77
  • IBRANCE (Drug) $121.74
  • XTANDI (Drug) $121.71
  • SUTENT (Drug) $118.89
  • Lenvima (Drug) $114.72

Explore

Data Sources

Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.

Hematology Doctors in Indianapolis

Dr. Luke Akard, M.d, M.D

Hematology — Payments: $510,050

Hematology $510,050

Attaya Suvannasankha, M.d, M.D

Hematology — Payments: $224,074

Hematology $224,074

Bert O'neil, Md, MD

Hematology — Payments: $160,161

Hematology $160,161

Felix Mensah, Md, MD

Hematology — Payments: $114,460

Hematology $114,460

Gregory Smith, Md, MD

Hematology — Payments: $75,453

Hematology $75,453

Pablo Bedano, Md, MD

Hematology — Payments: $56,782

Hematology $56,782